Subtype-specific clinical and prognostic relevance of tumor-expressedF5and regulatoryF5variants in breast cancer: the CoCaV study-Reference-Cited by-同舟云学术

Subtype-specific clinical and prognostic relevance of tumor-expressedF5and regulatoryF5variants in breast cancer: the CoCaV study

Published:2018-06-12 Issue:7 Volume:16 Page:1347-1356
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Tinholt M.¹²,Garred Ø.³,Borgen E.³,Beraki E.³,Schlichting E.⁴,Kristensen V.⁵⁶,Sahlberg K. K.⁵⁷,Iversen N.¹

Affiliation:

1. Department of Medical Genetics; Oslo University Hospital; Oslo Norway

2. Department of Haematology; Oslo University Hospital; Oslo Norway

3. Department of Pathology; Oslo University Hospital; Oslo Norway

4. Department of Breast and Endocrine Surgery; Oslo University Hospital; Oslo Norway

5. Department of Genetics; Institute for Cancer Research; Oslo University Hospital, Radiumhospitalet; Oslo Norway

6. Department of Clinical Molecular Biology (EpiGen); Akershus University Hospital; Lørenskog Norway

7. Department of Research; Vestre Viken; Drammen Norway

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.14151/fullpdf

Reference30 articles.

1. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status;Blackwell;J Clin Oncol,2000

2. Clinical and prognostic significance of coagulation assays in gastric cancer;Tas;J Gastrointest Cancer,2013

3. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study;Tinholt;BMC Cancer,2014

4. Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer;Ryden;Int J Cancer,2010

5. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF;Tinholt;Breast Cancer Res,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer;Cancers;2024-07-15

2. Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour;Cancers;2024-06-27

3. Coagulation factor V in breast cancer: a p53-regulated tumor suppressor and predictive marker for treatment response to chemotherapy;Journal of Thrombosis and Haemostasis;2024-06

4. The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy;Journal of Thrombosis and Haemostasis;2024-05

5. A Machine Learning Method for Predicting Biomarkers Associated with Prostate Cancer;Frontiers in Bioscience-Landmark;2023-12-06